UNMC — COVID-19 vaccines for children under 5 may soon receive U.S. Food & Drug Administration approval. Dr. Mark Rupp with the University of Nebraska College of Medicine says FDA committee hearings have been scheduled to occur in June, so approval could be just around the corner…
Courtesy/UNMC — Mark Rupp, MD, medical director of infection control and epidemiology at Nebraska Medicine and chief of the UNMC Division of Infectious Disease
Dr. Rupp says there’s a likelihood a vaccine will be available for the youngest children sometime later on this summer. Pfizer’s pediatric COVID-19 vaccine is 80.3% effective according to preliminary analysis. The results are based on clinical trials in which kids from six months to age 5 got three doses of the company’s vaccine.
